An2 Therapeutics, INC. (ANTX) SEC Filings — 2024
25 SEC filings for An2 Therapeutics, INC. (ANTX) in 2024.
Filings
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- AN2 Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- AN2 Therapeutics Appoints New Director, Discloses Officer Compensation — 8-K · Nov 5, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 28, 2024
- AN2 Therapeutics Files 8-K: Material Agreement — 8-K · Aug 19, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 14, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 13, 2024
- AN2 Therapeutics Q2 2024 Update — 10-Q · Aug 13, 2024
- An2 Therapeutics, INC. SC 13G Filing — SC 13G · Aug 12, 2024
- AN2 Therapeutics Announces Director Changes and Compensatory Arrangements — 8-K · Aug 8, 2024
- An2 Therapeutics, INC. SC 13G Filing — SC 13G · Jul 3, 2024
- AN2 Therapeutics Files 8-K on Security Holder Votes & Financials — 8-K · Jun 24, 2024
- AN2 Therapeutics Files Amendment No. 1 to Annual Report on Form 10-K — 10-K/A · May 14, 2024
- AN2 Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 19, 2024 — DEF 14A · Apr 26, 2024
- An2 Therapeutics, INC. SC 13G Filing — SC 13G · Apr 10, 2024
- AN2 Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
- AN2 Therapeutics Files 8-K on Financials — 8-K · Mar 28, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- An2 Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- An2 Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Janus Henderson Cuts AN2 Therapeutics Stake to Zero Voting Shares — SC 13G/A · Feb 12, 2024
- AN2 Therapeutics Files Routine 8-K for 'Other Events' — 8-K · Feb 12, 2024
- Adjuvant Capital Reduces AN2 Therapeutics Stake, Files SC 13G/A — SC 13G/A · Feb 9, 2024